Immunostimulatory nucleic acid molecules
View Patent ↗Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response and to redirect a Th2 response to a Th1 response in a subject are disclosed. Methods for treating atopic diseases, including atopic dermatitis, are disclosed.
1. An immunostimulatory oligonucleotide/delivery complex, comprising: an oligonucleotide covalently linked to the surface of a biodegradable delivery complex, wherein the oligonucleotide comprises the sequence 5′-C, G-3′, wherein the C is unmethylated and wherein the oligonucleotide is 8 to 100 nucleotides in length.
2. The complex of claim 1 , wherein said complex is antigen-free.
3. The complex of claim 1 , wherein the complex further comprises an antigen.
4. A composition comprising a complex of claim 1 and a pharmaceutically acceptable carrier.
5. The complex of claim 1 , wherein said oligonucleotide comprises the sequence 5′-T, C, G-3′.
6. The complex of claim 1 , wherein said oligonucleotide comprises the sequence 5′-C, G, pyrimidine, pyrimidine, C, G-3′.